- Report
- February 2026
- 250 Pages
Global
From €4016EUR$4,490USD£3,477GBP
- Report
- March 2026
- 273 Pages
Global
From €5233EUR$5,850USD£4,530GBP
- Report
- October 2025
- 160 Pages
Global
From €3003EUR$3,358USD£2,600GBP
€3533EUR$3,950USD£3,059GBP
- Report
- July 2024
- 147 Pages
Global
From €2236EUR$2,500USD£1,936GBP
- Report
- November 2025
- 132 Pages
Global
From €850EUR$950USD£736GBP
- Report
- April 2024
- 132 Pages
Global
From €850EUR$950USD£736GBP
The Plasma Therapeutics market is a subset of the Blood Banking industry, which involves the collection, processing, and storage of human blood and its components. Plasma Therapeutics is a specialized field that focuses on the therapeutic use of plasma, the liquid component of blood. Plasma is used to treat a variety of conditions, including hemophilia, immune deficiencies, and other bleeding disorders. Plasma Therapeutics also includes the development of new treatments and therapies, such as the use of plasma-derived proteins and other biologics.
Plasma Therapeutics is a rapidly growing field, with new treatments and therapies being developed to address a wide range of medical conditions. The market is highly competitive, with a number of companies offering products and services. Some of the major players in the Plasma Therapeutics market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more